Determinants of Myelosuppression in the Treatment of Non‐small Cell Lung Cancer with Cisplatin‐containing Chemotherapy

Data on 16 potential risk factors for myelosuppression were assessed in 134 patients who received either vindesine and cisplatin (VP) or mitomycin C, vindesine and cisplatin (MVP) for inoperable stage III or IV non‐small cell lung cancer in a randomized trial. Determinant factors for myelosuppressio...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Jpn J Cancer Res
Hoofdauteurs: Matsui, Kaoru, Masuda, Noriyuki, Uchida, Yasuo, Fukuoka, Masahiro, Negoro, Shunichi, Yana, Takashi, Kusunoki, Yoko, Kudoh, Shinzoh, Kawase, Ichiro, Kawahara, Masaaki, Ogawara, Mitsumasa, Kodama, Nagahisa, Kubota, Kaoru, Furuse, Kiyoyuki
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Blackwell Publishing Ltd 1996
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5921149/
https://ncbi.nlm.nih.gov/pubmed/8698630
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1349-7006.1996.tb00292.x
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items